

Properties
Name |
Content |
|---|---|
|
English name |
L-DOPA
|
|
Synonym |
|
|
Classification |
|
|
Item No. |
D13017
|
|
CAS |
|
|
Molecular formula |
|
|
Molecular weight |
|
|
Characteristic |
White or off white crystalline powder
|
|
Purity |
|
|
Usage |
|
|
Price |
Upon request
|
|
Storage conditions |
2-8℃ light blocking and drying
|
|
Validity period |
2 Years
|
|
Package |
100g;1kg;100kg;1t;5t
|
|
Notes |
|
Product Details
This product is currently one of the effective drugs for treating tremor paralysis, and is one of the precursors for the synthesis of norepinephrine, dopamine, etc. in the body, belonging to catecholamines. Levodopa can enter the brain through the blood-brain barrier and be converted into dopamine by dopa decarboxylase to exert its effects. Treatment for Parkinson’s disease and Parkinson’s syndrome; Treat hepatic coma, improve central function, make patients sober, and improve symptoms. Promote sleep and reduce fat; Increase bone density and reverse osteoporosis; The effect of increasing muscle strength and enhancing sexual ability.
Inquiry
Welcome To Inquire
- Tel: +86 18922937662
- E-mail: sales@gdpti.com
- Wechat: PTI142857
Related products
-
Thiazole-4-carboxylic acid
Medical Intermediates -
Jingxin, Indolol
Medical Intermediates -
ethyl 2-oxo-4-phenylbutyrate
Medical Intermediates -
NORGESTIMATE
Medical Intermediates